295 related articles for article (PubMed ID: 29211600)
1. Understanding the bone marrow microenvironment in hematologic malignancies: A focus on chemokine, integrin, and extracellular vesicle signaling.
Sison EAR; Kurre P; Kim YM
Pediatr Hematol Oncol; 2017; 34(6-7):365-378. PubMed ID: 29211600
[TBL] [Abstract][Full Text] [Related]
2. The interplay of leukemia cells and the bone marrow microenvironment.
Duarte D; Hawkins ED; Lo Celso C
Blood; 2018 Apr; 131(14):1507-1511. PubMed ID: 29487069
[TBL] [Abstract][Full Text] [Related]
3. The extracellular matrix: A key player in the pathogenesis of hematologic malignancies.
Sidhu I; Barwe SP; Gopalakrishnapillai A
Blood Rev; 2021 Jul; 48():100787. PubMed ID: 33317863
[TBL] [Abstract][Full Text] [Related]
4. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
5. Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.
Mukaida N; Tanabe Y; Baba T
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829353
[TBL] [Abstract][Full Text] [Related]
6. A hostel for the hostile: the bone marrow niche in hematologic neoplasms.
Krause DS; Scadden DT
Haematologica; 2015 Nov; 100(11):1376-87. PubMed ID: 26521296
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
Hartmann TN; Burger JA; Glodek A; Fujii N; Burger M
Oncogene; 2005 Jun; 24(27):4462-71. PubMed ID: 15806155
[TBL] [Abstract][Full Text] [Related]
8. Molecular Players in Hematologic Tumor Cell Trafficking.
Redondo-Muñoz J; García-Pardo A; Teixidó J
Front Immunol; 2019; 10():156. PubMed ID: 30787933
[TBL] [Abstract][Full Text] [Related]
9. Delta-like homologue 1 and its role in the bone marrow niche and hematologic malignancies.
Benetatos L; Hatzimichael E
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):451-5. PubMed ID: 25066037
[TBL] [Abstract][Full Text] [Related]
10. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.
Chen Z; Teo AE; McCarty N
Clin Cancer Res; 2016 Jan; 22(1):187-99. PubMed ID: 26350264
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicle-mediated remodeling of the bone marrow microenvironment in myeloid malignancies.
Hayashi Y; Nishimura K; Tanaka A; Inoue D
Int J Hematol; 2023 Jun; 117(6):821-829. PubMed ID: 37041345
[TBL] [Abstract][Full Text] [Related]
12. Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.
Becker PS
ScientificWorldJournal; 2012; 2012():856467. PubMed ID: 22346731
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles in hematological malignancies.
Litwińska Z; Łuczkowska K; Machaliński B
Leuk Lymphoma; 2019 Jan; 60(1):29-36. PubMed ID: 29745272
[TBL] [Abstract][Full Text] [Related]
14. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance.
Meads MB; Hazlehurst LA; Dalton WS
Clin Cancer Res; 2008 May; 14(9):2519-26. PubMed ID: 18451212
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental regulation of hematopoietic stem cells and its implications in leukemogenesis.
Seshadri M; Qu CK
Curr Opin Hematol; 2016 Jul; 23(4):339-45. PubMed ID: 27071022
[TBL] [Abstract][Full Text] [Related]
16. T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.
Vadillo E; Dorantes-Acosta E; Pelayo R; Schnoor M
Blood Rev; 2018 Jan; 32(1):36-51. PubMed ID: 28830639
[TBL] [Abstract][Full Text] [Related]
17. Tetraspanins set the stage for bone marrow microenvironment-induced chemoprotection in hematologic malignancies.
Quagliano A; Gopalakrishnapillai A; Barwe SP
Blood Adv; 2023 Aug; 7(16):4403-4413. PubMed ID: 37561544
[TBL] [Abstract][Full Text] [Related]
18. The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance.
Shain KH; Landowski TH; Dalton WS
Curr Opin Oncol; 2000 Nov; 12(6):557-63. PubMed ID: 11085455
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the messages carried by extracellular vesicles in hematological malignancies.
Longjohn MN; Hudson JBJ; Smith NC; Rise ML; Moorehead PC; Christian SL
Blood Rev; 2021 Mar; 46():100734. PubMed ID: 32736879
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.
Yuan S; Liu Z; Xu Z; Liu J; Zhang J
J Hematol Oncol; 2020 Jul; 13(1):91. PubMed ID: 32660524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
